Found Weight Loss Program: How It Works and Medication Options

This piece belongs to the PlexusDx Education Hub, where we cover weight-management protocols, GLP-1 medications, and the genetic groundwork behind every outcome. Browse every Peptides & GLP-1 guide.

This is independent editorial analysis. PlexusDx has no business ties to Found, earns no affiliate revenue from it, and was not compensated to write this review.

Full head-to-head: PlexusDx vs Found →

People typing "Found weight loss" generally want to know how the program produces results and what the medication track looks like day to day. Below we break down the structure of Found's weight-loss offering — how care is delivered, which medications sit inside it, and what shapes the monthly bill — and then explain why two people following the same plan can see very different numbers. As of April 2026.

What the Found weight-loss program is built around

Found's weight-loss offering is a subscription telehealth service organized around medication plus support. Care is virtual: a licensed provider reviews your case and, when appropriate, prescribes to a retail pharmacy for FDA-approved brand products or a 503A compounding pharmacy for compounded semaglutide or tirzepatide, with follow-up alongside. Program structure and current pricing are documented on Found's official website.

Medication options within the weight-loss track

The medications inside a weight-loss track are GLP-1 receptor agonists and, in the dual-agonist case, tirzepatide. Depending on eligibility and the dispensing pathway, an order may be an FDA-approved brand product or a compounded preparation from a licensed 503A pharmacy. The program does not invent a new drug class; it delivers established compounds through a telehealth wrapper aimed at weight management specifically.

The provider relationship and follow-up cadence

A weight-loss subscription is not a one-time transaction. After intake, a licensed clinician evaluates eligibility and, if you qualify, issues a prescription. From there, scheduled follow-up supports dose titration and manages side effects as your body adjusts. The provider type — physician, nurse practitioner, or physician assistant — and the touchpoint frequency vary by brand and tier.

What drives the monthly number

Cost in a weight-loss program is assembled from several parts: the program fee, the medication, your subscription tier, and whether you are dispensed a brand or compounded product. Across the telehealth GLP-1 market as of April 2026, monthly totals commonly range from roughly $200 to $700+, with substantial variance. Because these numbers change frequently, verify current pricing at Found's official website before enrolling.

Evidence behind GLP-1 weight management

The results people associate with these programs come from the compounds, not the platform. Semaglutide and tirzepatide anchor the weight-management evidence base: STEP studied semaglutide (NEJM 2021), SURMOUNT studied tirzepatide (NEJM 2022), and SURMOUNT-OSA extended tirzepatide into obstructive sleep apnea (NEJM 2024). Effect sizes differ by compound, dose, and population, and any individual's trajectory is their own.

The genetic variable no subscription reads

Here is the layer none of these telehealth workflows examine: the inherited biology that sets the stage before any GLP-1 molecule arrives. Inherited differences in FTO (fat-mass and obesity-associated), MC4R (a melanocortin receptor governing appetite), and TCF7L2 (tied to glucose handling and GLP-1 secretion) help explain why identical protocols produce different numbers on the scale. These are pathway-level markers. They do not predict how you will respond to any particular drug, but they describe the metabolic terrain a prescriber is writing into. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights across that terrain, mapping appetite regulation, satiety, and energy-balance biology so a conversation with your own clinician starts from data rather than guesswork. It is not a pharmacogenomic test and never forecasts a medication's effect.

Through its Weight Management Protocols, PlexusDx dispenses semaglutide and tirzepatide as Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. What differs from a weight-loss subscription alone is the genetic context layered underneath the medication, not the medication class itself.

Not affiliated: PlexusDx has no affiliation and no commercial relationship with Found or the other programs discussed in this review.

Related reading on PlexusDx: Wegovy Weight Loss Pills, GLP 1 Dosage For Weight Loss, GLP 1 Weight Loss Before And After, Average Weight Loss On Ozempic.

This article is educational. PlexusDx has no affiliation or commercial relationship with Found. PlexusDx offers semaglutide and tirzepatide via its own Weight Management Protocols, and this review compares weight-loss approaches in the telehealth space. The Precision Peptide Genetic Test analyzes gene–pathway influence and does not predict response to any drug. Consult a qualified healthcare provider before beginning any protocol.

See how PlexusDx approaches weight care: explore the Weight Management Protocols, or begin upstream with the Precision Peptide Genetic Test to understand the biology behind your results.

Frequently Asked Questions

How much weight can you expect to lose on a program like Found?

Weight change depends on the compound, dose, adherence, and individual biology, and it varies widely. Trials like STEP and SURMOUNT document average results for semaglutide and tirzepatide, but averages are not promises. Your own trajectory is personal, which is exactly why upstream context matters before setting expectations.

Does Found guarantee weight-loss results?

No responsible telehealth program guarantees a specific outcome. A weight-loss subscription provides clinician-authorized medication and support, but results hinge on the compound, your response, and adherence over time. Treat any language implying a fixed result with caution and confirm program terms on the brand's own site.

What happens if the medication stops working?

Response can plateau, and clinicians manage this through follow-up — adjusting dose within labeled ranges, revisiting the plan, or discussing alternatives. This is handled clinically with your provider rather than by the subscription itself. Ongoing follow-up is one reason these programs are structured as continuing care, not a single purchase.

Can genetics explain different weight-loss outcomes?

Genetics is one contributing factor. Pathway-level variants in FTO, MC4R, and TCF7L2 shape appetite, satiety, and glucose handling, which influence the metabolic terrain a medication acts on. The Precision Peptide Genetic Test maps that context but does not predict how any specific drug will perform for you.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.